Subcortical atrophy and cognition
暂无分享,去创建一个
Linda Douw | Frederik Barkhof | Hugo Vrenken | Menno M. Schoonheim | F. Barkhof | M. Schoonheim | J. Geurts | L. Douw | H. Vrenken | C. Polman | V. Popescu | F. C. Rueda Lopes | O. T. Wiebenga | Oliver T. Wiebenga | Chris H. Polman | Jeroen J.G. Geurts | Veronica Popescu | Fernanda C. Rueda Lopes | O. Wiebenga
[1] M. Sá,et al. Cognitive Dysfunction in Multiple Sclerosis , 2012, Front. Neur..
[2] R. Benedict,et al. Risk factors for and management of cognitive dysfunction in multiple sclerosis , 2011, Nature Reviews Neurology.
[3] Stephen M. Rao,et al. Cognitive dysfunction in multiple sclerosis. , 1991, Neurology.
[4] M. Belke,et al. Men and women are different: Diffusion tensor imaging reveals sexual dimorphism in the microstructure of the thalamus, corpus callosum and cingulum , 2011, NeuroImage.
[5] D. Chard,et al. Predicting the development of multiple sclerosis , 2011, Neurology.
[6] R. Rudick,et al. Gray matter atrophy in multiple sclerosis: A longitudinal study , 2008, Annals of neurology.
[7] S. Tiwari-Woodruff,et al. Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment. , 2007, Proceedings of the National Academy of Sciences of the United States of America.
[8] S. Rombouts,et al. The contribution of MRI in assessing cognitive impairment in multiple sclerosis , 2010, Neurology.
[9] Alan C. Evans,et al. Age- and Gender-Related Differences in the Cortical Anatomical Network , 2009, The Journal of Neuroscience.
[10] Stephen M. Smith,et al. A Bayesian model of shape and appearance for subcortical brain segmentation , 2011, NeuroImage.
[11] Francis Eustache,et al. Quantification and clinical relevance of brain atrophy in multiple sclerosis: a review , 2009, Journal of Neurology.
[12] M. Calabrese,et al. The predictive value of gray matter atrophy in clinically isolated syndromes , 2011, Neurology.
[13] Robert Zivadinov,et al. Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis , 2011, Journal of Neurology.
[14] Stephen M. Smith,et al. Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.
[15] Hirofumi Ochi,et al. [Cognitive impairment in multiple sclerosis]. , 2014, Brain and nerve = Shinkei kenkyu no shinpo.
[16] Robert Zivadinov,et al. Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. , 2006, Archives of neurology.
[17] M. Battaglini,et al. Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes , 2010, Neurology.
[18] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[19] C. Enzinger,et al. Gender differences in MRI studies on multiple sclerosis , 2009, Journal of the Neurological Sciences.
[20] S. Reingold,et al. Defining the clinical course of multiple sclerosis , 1996, Neurology.
[21] K. Cosgrove,et al. Evolving Knowledge of Sex Differences in Brain Structure, Function, and Chemistry , 2007, Biological Psychiatry.
[22] F. Barkhof,et al. Functional adaptive changes within the hippocampal memory system of patients with multiple sclerosis , 2012, Human brain mapping.
[23] S. Sorbi,et al. Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. , 2001, Archives of neurology.
[24] C. J. Stam,et al. Cognition is related to resting-state small-world network topology: an magnetoencephalographic study , 2011, Neuroscience.
[25] D. Louis Collins,et al. Evaluation of automated techniques for the quantification of grey matter atrophy in patients with multiple sclerosis , 2010, NeuroImage.
[26] V. Dousset,et al. MRI predictors of cognitive outcome in early multiple sclerosis , 2011, Neurology.
[27] Y. Ao,et al. Neuroprotection mediated through estrogen receptor-α in astrocytes , 2011, Proceedings of the National Academy of Sciences.
[28] Daniel Rueckert,et al. An evaluation of four automatic methods of segmenting the subcortical structures in the brain , 2009, NeuroImage.
[29] J. L. Cox,et al. Gender-related differences in MS: a study of conventional and nonconventional MRI measures , 2009, Multiple sclerosis.
[30] David H. Miller,et al. Imaging outcomes for neuroprotection and repair in multiple sclerosis trials , 2009, Nature Reviews Neurology.
[31] Stephen M. Rao,et al. Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS , 2009, Multiple sclerosis.
[32] Rhonda R. Voskuhl,et al. Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)α and ERβ ligand treatment , 2007, Proceedings of the National Academy of Sciences.
[33] F. Barkhof,et al. Clinical correlations of brain lesion distribution in multiple sclerosis , 2009, Journal of magnetic resonance imaging : JMRI.
[34] O. Kantarci,et al. Gray Matter Atrophy Is Related to Long-Term Disability in Multiple Sclerosis , 2009 .
[35] S. Rivest,et al. Estrogen Receptor Transrepresses Brain Inflammation , 2011, Cell.
[36] M. Filippi,et al. Functional MR Imaging Correlates of Neuropsychological Impairment in Primary-Progressive Multiple Sclerosis , 2010, American Journal of Neuroradiology.
[37] Rohit Bakshi,et al. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. , 2004, Archives of neurology.
[38] C R G Guttmann,et al. Thalamic atrophy and cognition in multiple sclerosis , 2007, Neurology.
[39] C. Caltagirone,et al. Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis , 2004, Journal of Neurology.
[40] P. Rieckmann,et al. The natural history of secondary progressive multiple sclerosis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.